Locus licenses CRISPR tech to Janssen in potential $818m deal
Presse/medie
09/01/2019
Referencer
Locus licenses CRISPR tech to Janssen in potential $818m deal
Rory O'Neill, 1h
Life Scienes Intellectual Property Review (LSIPR)
https://www.lifesciencesipreview.com/news/locus-licenses-crispr-tech-to-janssen-in-818m-deal-3323
ID: 211113141